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ABSTRACT
HIV-1 integrase integrates retroviral DNA through
30-processing and strand transfer reactions in the
presence of a divalent cation (Mg
2+ or Mn
2+). The
a4 helix exposed at the catalytic core surface is
essential to the specific recognition of viral DNA.
To define group determinants of recognition, we
used a model composed of a peptide analogue of
the a4 helix, oligonucleotides mimicking processed
and unprocessed U5 LTR end and 5mM Mg
2+.
Circular dichroism, fluorescence and NMR
experiments confirmed the implication of the a4
helix polar/charged face in specific and non-
specific bindings to LTR ends. The specific binding
requires unprocessed LTR ends—i.e. an unaltered
30-processing site CA#GT30—and is reinforced by
Mg
2+ (Kd decreases from 2 to 0.8nM). The latter
likely interacts with the ApG and GpT30 steps
of the 30-processing site. With deletion of GT30,
only persists non-specific binding (Kd of 100kM).
Proton chemical shift deviations showed that
specific binding need conserved amino acids in
the a4 helix and conserved nucleotide bases and
backbone groups at LTR ends. We suggest a
conserved recognition mechanism based on both
direct and indirect readout and which is subject to
evolutionary pressure.
INTRODUCTION
HIV-1 cDNA integration into the host cell chromosome
is catalyzed by the virus enzyme integrase (IN) (1,2).
The reaction involves two separate steps: 30 processing
of the newly synthesized cDNA in the cytoplasm, and
strand transfer in the nucleus (3). Processed cDNA and
IN are imported into the nucleus via a preintegration
complex (PIC) including viral and host proteins (4).
The 30-processing and the strand transfer reactions have
been modeled in vitro using puriﬁed recombinant IN and a
double stranded DNA fragment (21 base pairs) mimicking
either the U5 or the U3 LTR end. IN alone, in the
presence of divalent cations, performs both the 30 process-
ing and the DNA strand transfer reactions (2). The DNA
fragment plays the role of both the donor (virus DNA)
and acceptor (cell DNA).
The IN monomer is a 32-kDa protein comprising three
structural domains (5,6). The N-terminal domain (Nt:
residues 1–49) has several helices and adopts a compact
structure ﬁxed by zinc atom coordination (7). The central
domain of the catalytic core (CC: residues 50–212) bearing
the active site acidic residues, Asp64, Asp116 and Glu152
(the so-called DDE catalytic triad) (8–12), belongs to a
sup family of DNA/RNA strand transferases/nucleases
(13–15). The C-terminal domain (Ct: residues 213–288)
incorporates a Src-like domain and is involved in DNA
host recognition (16).
The high resolution 3D structure of the entire enzyme
bound or unbound to DNA has not yet been resolved. The
main handicap to obtaining crystals for X-ray studies or in
performing an NMR analysis of IN is the weak solubility
of the protein. However, a low resolution structure of IN
at the DNA contact level has been derived by electronic
microscopy (17). This reveals an asymmetric tetrameric IN
assembly, contrasting the symmetric structure provided
by theoretical or semi-empirical models (18–20).
IN uses a divalent cation (either Mn
2+ or Mg
2+)a s
co-factor (21), similar to several enzymes that perform
nucleic acid phosphoryl-transfer reactions. Mg
2+ may be
the relevant factor for IN function in vivo as its
intracellular concentration is much higher than that of
Mn
2+ (1mM vs 10
 4mM). Moreover, Mn
2+ augments
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acceptance of sequence variations at the LTR extremities
(23), and several mutations aﬀecting Mn
2+ are ineﬀective,
which is not the case with Mg
2+ (23,24). This diﬀerence in
the selection of Mn
2+ and Mg
2+ also aﬀects the eﬃciency
of IN inhibitors and has been taken into account in the
design of raltegravir and elvitegravir drugs (25). How does
the divalent cation in IN function? Many uncertainties still
exist. The cation may introduce conformational changes
to the catalytic site, thus conferring an active structure,
but it could also serve as an intermediate permitting the
binding of IN to the DNA substrate (26,27).
Previously, to study binding of IN to DNA we have
used a model approach involving an analogue (K156) of
the amphiphile a4 helix lying at the surface of the IN CC
(Figure 1A), and an oligonucleotide corresponding to the
U5 LTR end (28). Results have highlighted the roles of
Lys156 and Lys159 of the a4 helix and the need for an
unprocessed LTR DNA end to achieve speciﬁc interaction
(28). In a following paper we have shown that the a4 helix
is the DNA recognition helix of the HTH (helix turn helix)
motif (29). Here we aim to provide greater details on the
interaction of the a4 helix with LTR ends in the presence
of Mg
2+. Our approach involved circular dichroism (CD),
ﬂuorescence (quenching and anisotropy) and
1H-NMR
spectroscopy. Results were consistent with IN recognizing
viral DNA via both direct and indirect readout, in which
the binding is optimal only when LTR ends are
unprocessed and divalent cations are present.
MATERIALS AND METHODS
The peptides and oligonucleotides used in this study are
shown in Figure 1. Some of their characteristics are also
presented.
Peptides
Two versions of the peptide K156 (K156-Y and K156-W)
(Figure 1B) were synthesized as previously reported (28).
K156 is a helix-stabilized version of the helical a4 peptide
(residues 147 to residues 169in CC) (28). Brieﬂy, several
residues were replaced in parts of the helix deemed not
important for DNA recognition by residues promoting
helix formation. The K156 peptide backbone conforma-
tion had greater resemblance to the a4 helix in the protein
context than the a4 peptide taken in isolation. It was also
less aggregation prone and more adapted to the study of
speciﬁc interactions, that are highly conformation depen-
dent. The Tyr (Y) or Trp (W) aromatic residues added to
the C-terminus enabled peptide concentration estimation
from absorbances in UV spectra, using molar absorption
coeﬃcients of 1280 and 5600M
 1cm
 1 at 280nm for
the tyrosine-containing peptide and the tryptophan-
containing peptide, respectively.
The wheel presentation of the a4 helix and K156
peptide provided an illustration of the hydrophobic and
hydrophilic domains and showed the positions of the
substitutions made in the helix (Figure 1C).
Oligonucleotides
The two oligonucleotides were purchased from
Eurogentec (Belgium) (Figure 1D). The choice of
monomolecular hairpin-forming oligonucleotides rather
than bimolecular duplex-forming oligonucleotides was
motivated by the need for double helix stability under
the low concentrations used in ﬂuorescence and CD
experiments (10
 9 to 10
 5M). The oligonucleotide
sequences reproduce an U5 LTR end that is unprocessed
and processed (deletion of GT30 on the upper strand). The
central thymine of the three thymine-loop bears a
ﬂuorescein reporter allowing ﬂuorescence measurements.
The ﬂuorescein is thought not to interfere with the binding
of IN to LTR ends. Nonetheless, a version without
ﬂuorescein was prepared for CD and NMR studies.
Fluorescence measurements
The intrinsic ﬂuorescence quantum yield and ﬂuorescence
anisotropy studies were carried out with a Jobin-Yvon
Fluoromax II instrument (HORIBA Jobin Yvon,
France) equipped with an Ozone-free 150W xenon
lamp. Samples (800ml) were placed at 5 C in thermally
jacketed 1cm 0.5cm quartz cells. At least ten
measurements for each titration point were recorded
with an integration time of 1s. Fluorophores were either
tryptophan or ﬂuorescein purposely ﬁxed to the peptide or
the oligonucleotide, respectively.
In ﬂuorescence anisotropy, (A ¼ð I‘   GI?Þ=
ðI‘ þ 2GI?Þ), parallel (III) and perpendicular (I?)
emission components were measured in L-format with
4nm excitation and emission slit widths. With ﬂuorescein
as the ﬂuorophore, the excitation was performed at
488nm and the emission was recorded at 516nmin the
case of LTR34 and at 515nmin the case of LTR32.
Fluorescein-labeled oligonucleotides were diluted to the
desired concentration (10nM) in 800ml of assay buﬀer
(Na/Na2 phosphate, pH 6, I=0.1 in the presence or
absence of 5mM MgCl2). Peptides were stepwise diluted.
For each anisotropy measurement, the parallel ðIQÞ and
the perpendicular I? ðÞ intensities of the background
solution (i.e. buﬀer and protein contributions) were auto-
matically subtracted from the sample value, calculating
the G-value correction each time.
In quenching experiments, intrinsic ﬂuorescence of
K156-W was measured at a concentration of 400nM in
800ml of reaction buﬀer (with or without 5mM MgCl2).
Excitation at 290nm provided an emission between 300
and 480nm, using 2 and 5nm excitation and emission slit
widths, respectively. Maximal emission was measured at
355nm. Titration isotherms illustrating the binding
of Mg
2+ to K156 were expressed as 1 F/F
0, where F
0
is the ﬂuorescence in the absence of Mg
2+.
CD spectroscopy
CD spectra were recorded on a CD6 dichrograph
(HORIBA Jobin Yvon, France). Measurements were
calibrated with (+)-10-camphorsulfonic acid. Oligonuc-
leotide and peptide concentrations varied from 6 to
12mM in phosphate buﬀer pH 6, I=0.1, with and
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2+. Samples were placed in jacketed cells with
a 1mm path length, minimizing thermal drift. To allow
the solutions to reach their equilibrium state, these were
incubated for 10min at the chosen temperature. Spectra,
recorded in 1nm steps, were averaged over ten scans and
corrected for the base line. They were presented as diﬀer-
ential molar absorptivity per residue, e (M
 1cm
 1), as
a function of wavelength, between 260 and 185nm
for peptides and between 200 and 330nm for DNA,
peptide–DNA complexes or peptide alone. In the latter
case, aliquots of peptide were added to LTR34 or
LTR32 (12mM) and the control spectrum of the LTR
without ligand was subtracted from that of the complex.
Eﬀects of b-hydroxycarbonyl compounds were estimated
by adding aliquots of the drug in the presence and absence
of Mg
2+. The a-helical content of peptides was obtained
using the relation: Pa= [e222 10] (Pa: percentage of
a-helix; e222: CD per residue at 222nm) (30).
NMR spectroscopy
Proton NMR spectra were recorded on Bruker Avance
500 and 700MHz (equipped with a TCI cryo-probe)
spectrometers and were processed with the SPARKY
program. Samples (500ml) were prepared with 1mM
K156 and LTR34 diluted in 90% phosphate buﬀer
(10mM Na/Na2 pH 6.5) 10%
2H2O. TSP was used as
an internal chemical shift reference. Standard two-
dimensional NMR experiments were recorded at 10 C
(31). Spectral widths were enlarged to 12 (for the
peptide) and 20p.p.m. (for the DNA and the complexes).
The NOESY mixing times were ﬁxed at 150, 200, 300 and
450ms. The Clean-TOCSY (32) sequences were collected
with MLEV-17 spin-locking ﬁxed at 40, 60, 80, 100 and
120ms. Solvent suppression was achieved by applying a
WATERGATE pulse sequence. NOE relative intensities
were measured from 300ms mixing time NOESY spectra
with solvent presaturation. Intensities (volume and height
of connectivity) were determined by the Sparky program
(Goddard and Kneller, University of California, San
Francisco) and were conﬁrmed by the TopSpin program
(Bruker). The
3JaHNH coupling constants were measured
on NH peaks in 1D NMR spectra. Chemical shifts were
determined from both TOCSY and NOESY spectra.
RESULTS AND DISCUSSION
Design of the peptide K156
The conformation of the a4 peptide in solution is mainly
unordered (28) and is therefore very diﬀerent of the a4
helix structure observed in the context of the protein
(Figure 1A). Thus, the a4 peptide cannot be used to give
an account of the role of the a4 helix in the recognition of
DNA the enzyme. A more suitable model is peptide K156,
a structural analogue of the a4 peptide displaying a higher
helical content and thereby a pre-organized structure for
interaction (Figure 1B). Most amino acid substitutions
were made in ensuring that hydrophobic and hydrophilic
surfaces were not signiﬁcantly altered (Figure 1C).
We also took into account the previously reported data
of mutagenesis (33) to ensure that no amino acid
important to 30-processing was replaced. Substitutions
were as follows: (i) Gly149–Ala, Gly163–Ala, Val151–
Leu, Ile161–Leu, Ile162–Leu (alanine and leucine being
strongly involved in helix formation, especially
compared with side chain deprived glycine and b-
branched valine/isoleucine, respectively); and (ii) Val150
Lys and Ser153 Glu, allowing the formation of two i–
i+3 pairs with stabilizing electrostatic interactions
between positively and negatively charged side chains
(Lys150 Glu153 and Glu153 Lys156). Examination of
results of the variation in HIV-1 group M IN indicates
that among all the substitutions performed in K156,
only one, that of Ser153 (Ser153 Glu), confers resistance
to raltegravir and elvitegravir (34).
Binding of Mg
2+ to LTR34 and LTR32
The in vivo activity of Mg
2+ is similar to that of a solution
with 0.5–1.0mM Mg
2+ and 0.15M monovalent salt (35).
Both monovalent and divalent cations interact with the
DNA surface and neutralize the phosphate negative
charges, decreasing the repulsive forces between negative
or positive charges. Mg
2+ is a compact ion with a small
atomic radius, facilitating its coordination with oxygen
atoms in DNA (36,37). It is also a net hydrogen bond
donor through its rigid octahedral primary solution shell
(38); hydrogen bonds occur with bases in particular
sequences (39,40). In fact, Mg
2+ is involved in
sequence-speciﬁc binding to the major and minor
grooves of DNA, as well as non-speciﬁc binding to
backbone phosphates (41). Often, the structures, the
dynamics and the ligand interactions are modiﬁed by
the cation, but each eﬀect depends on the groove where
the binding occurs.
We used CD and ﬂuorescence spectroscopy to examine
the eﬀect of Mg
2+ on both unprocessed LTR34 DNA and
processed LTR32 DNA. We also studied
1H NMR data in
the case of LTR34 DNA. In CD experiments addition of
MgCl2 (to a ﬁnal concentration of 5mM) to a solution of
LTR34 or LTR32 in phosphate buﬀer pH 6, at 5 C, did
not produce noticeable change in the intensity or in the
shape of spectra, which continued to present B DNA
characteristics with a positive signal at  280nm and a
negative one at  250nm (data not shown). The NMR
analysis of LTR34 DNA in the absence of Mg
2+ has
been previously reported (42). Despite the large number
and poor dispersion of proton resonances inherent
to nucleic acids and the rather long size of our
oligonucleotide (a stem of 17 base pairs), almost all the
1H-resonances were assigned. The addition of Mg
2+ to
LTR34 did not signiﬁcantly modify the chemical shifts
(Supplementary Table S1). LTR34 maintains the B-
DNA form with or without Mg
2+, which is consistent
with the CD results.
Although Mg
2+ does not visibly modify the DNA con-
formation, the titration isotherms obtained by ﬂuores-
cence anisotropy show that the divalent cation binds to
DNA. A deep transition in the curve occurs in the
millimolar range for both LTR34 and LTR32 (data not
shown). Curve analysis considering a simple two-
state reversible equilibrium between Mg
2+ ions and
Nucleic Acids Research, 2009,Vol.37, No. 22 7693DNA, which is an oversimpliﬁed approach (43) using
‘GraphPad Prism’ (Non-linear ‘Least Squares’), provides
Kd values of  60mM for LTR34 and  80mM for
LTR32.
Binding of Mg
2+ to K156
The interaction of Mg
2+—which is assumed to act as a
cofactor for the catalytic reaction and as a stabilizer of the
IN–DNA complex—with the K156 peptide, was assessed
A
C
B 147 157 166
4: SQGVVESMNKELKKIIGQVR
K156Y : SQAKLEEMNKELKKLLAQVRAQY
K156W : SQAKLEEMNKELKKLLAQVRAQW 
D LTR34 :
   T20G21G22A23A24A25A26T27C28T29C30T31A32G33C34A35G36T373′
T19
   T18C17C16T15T14T13T12A11G10A9G8A7 T6 C5 G4   T3 C2 A15′
LTR34fm : 
      TGGAAAATCTCTAGCAGT  3′
F-T
      TCCTT TTAGAGATCGTCA  5′
LTR32 :   
   TGGAAAATCTCTAGCA       3′
T
   TCCTT TT AGAGATCGTCA  5′
LTR32fm : 
      TGGAAAATCTCTAGCA       3′
F-T
      TCCTTTT AGAGATCGTCA  5′
A167 
K160 
E153
Q168 
L 161 
M 154 
S 147 
V165 
L158 
L151 
 Q148 
 N155 
L 162 
Y(W)169 
A149 
K156
A163 
Q164
E157
K150 
K156
E152
K159
R166 
I 161 
M 154 
S 147 
V165 
L158 
V151 
 Q148 
 N155 
 I 162 
E152 
K159 
R166
G149
K156
G163
Q164
E157
V150
4
K160 
S153
Figure 1. (A) Crystal structure of the dimeric catalytic core domain showing the a4 helix at the protein surface [after Dyda et al. (10)]. (B) Peptides
used in this study: sequences of a4 and analogues K156Y and K156W with the substituted and added residues in bold. (C) Wheel representations of
a4 (top) and K156 (bottom) with the substituted and added residues in bold. (D) Oligonucleotides used in this study: unprocessed LTR34 under the
hairpin form (three thymine loop and 17 base pair stem) numbered from 50 to 30, the processed oligonucleotide LTR32, and their ﬂuoresceinated
versions LTR34fm and LTR32fm.
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spectra of K156 in the presence and absence of Mg
2+
are given in Supplementary Figure S1. In the absence of
Mg
2+, the CD spectra of K156 at 12mM displayed two
negative bands, at  225 and  208nm, and a positive
band, at  190nm, typical of the a helix (28). The a
helix content based on CD intensity at  225nm (30) is
of  25%. This partly depends on the composition and
sequence of the peptide. There are several negatively
charged Glu and positively charged Lys residues display-
ing i+3 or i+4 spacing within the K156 sequence. Their
distribution allows either ion pair formation (Lys150–
Glu153, Glu152–Lys156, Glu153–Lys156 and Glu157–
Lys160) or ion pair repulsion (Glu153–Glu157, Lys156–
Lys159 and Lys156–Lys160). The sum of the eﬀects results
either in a stabilization or destabilization of the helix, but
salts modulate the intensity of eﬀects.
We found that addition of MgCl2 to K156 slightly
increased band intensities, and thus helix stability. Our
previous NMR analysis, which mainly investigated the
K156 backbone, has shown that K156 adopts a rather
stable helix structure in buﬀer and aqueous media at pH
6 (28). Here, we extended the analysis to amino acid side
chains groups, as side chains are directly implicated in
the DNA–peptide interactions. We measured K156
chemical shifts in the presence and absence of Mg
2+
(Supplementary Table S2). The addition of Mg
2+ to
K156 produced some weak chemical shift variation and
a selective broadening of correlations, visible in the
TOCSY spectra. The b and g correlations of the catalytic
acid residue Glu152 resulted in a weak increase in inten-
sity. In contrast, the aH, NH and gH protons of Gln168,
the bH protons of Lys159, the gH proton of Lys160, and
the bH and gH protons of Leu161 displayed a weak
decrease in intensity. One of the d proton signals of
Lys159 was no longer visible. The only noticeable
chemical shift variation involved the gH proton of
Glu153, which led to a shift of  0.1p.p.m.
Ten
3JaHNH were accessible in the 1D spectra of K156
recorded in the presence and the absence of Mg
2+. The
residues analyzed were Ala149, Lys150, Glu152, Met154,
Asn155, Asp157, Lys159, Lys160, Ala163 and Ala167,
which are evenly distributed along the entire chain
length and, thereby may be used as good indicators for
the whole backbone structure. The average of
3JaHNH
values in the absence of Mg
2+ was 4.4±0.3Hz, a value
consistent with that found for other helical structures (31).
The addition of Mg
2+ decreased the average value to
4.2±0.3Hz, suggesting a weak helix stabilization. The
observed decrease in
3JaHNH values was accompanied by
a variation in several typical NH(i)-NH(i+1) and aH(i)-
NH(i+1) NOEs. For instance, NH(i)-NH(i+1) correlations
of the linked residues Ala149–Lys150, Glu153–Met154
and Asn155–Lys156, which show well-delineated cross-
peaks, resulted in a noticeable increase of intensity (140,
70 and 40, respectively), consistent with helix stabilization.
We used ﬂuorescence spectroscopy to determine the
thermodynamic variables for Mg
2+ and K156 binding.
The signal of tryptophan (excitation at 290nm, emission
at 300–480nm) purposely incorporated at the C-end of
the peptide was used as the ﬂuorophore. The change in
ﬂuorescence induced by Mg
2+ was weak, indicating that
the conformational change was also weak, and was likely
limited to only some Mg
2+-binding positions. Treatment
of the titration curve yielded an apparent Kd value of
2.5mM (data not shown).
CD analysis of the peptide binding to DNA
CD is a convenient method for analyzing both peptide and
oligonucleotide conformations, and conformational
changes accompanying complex formation. The CD
spectra of LTR34 and LTR32 were typical of B DNA,
and these spectra remained unchanged upon Mg
2+
addition (data not shown). In contrast, there were slight
changes in the K156 spectrum on Mg
2+ addition, which is
consistent with a more stable helix (Supplementary Figure
S1). We investigated the binding of K156 to processed and
unprocessed LTR ends in the presence of Mg
2+. Previous
experiments performed in the absence of Mg
2+ have
shown that the GT30 dinucleotide deleted upon
30-processing is essential for the speciﬁc binding between
IN and virus DNA (28). Mixing LTR34 and K156 in the
presence of Mg
2+ resulted in a spectrum in the 190–
260nm region that clearly diﬀered from the sum of indi-
vidual K156 and LTR34 spectra. Since no changes were
detected between 260 and 300nm, an UV region rather
speciﬁc to DNA, we deduced that the changes observed
in the 190–260nm UV region were due to conformational
variations aﬀecting the sole peptide. The diﬀerence spectra
(i.e. spectra of DNA–K156 complexes at the 1:1 ratio
minus the spectrum of unbound K156) showed that
LTR34 stabilizes the K156 helix, but LTR32 does not,
thereby conﬁrming the contribution of the LTR GT30
dinucleotide to complex formation (Figure 2A and B).
Analysis of the peptide binding to DNA by ﬂuorescence
Direct implication of the a4 helix in interactions with LTR
ends has been suggested in several in vitro and in vivo
experiments (23,28,44–57). Here, the DNA–a4 peptide
binding analysis was performed by monitoring the
anisotropy signal of ﬂuorescein linked to the hairpin
oligonucleotides (Figure 1D). The binding isotherms
were related to the total average amount of K156
binding (Figure 3A and B). The LTR34 isotherm had
two phases: a small increase of anisotropy accompanied
by an inﬂection in the nanomolar range, followed by a
steeper increase with an inﬂection in the micromolar
range. Curve analysis provided a Kd1 value of  0.8nM
(ﬁrst binding) and a Kd2 value  100mM (second
binding). In contrast, the binding of K156 to LTR32
provided a monophasic isotherm with a Kd value
 100mM, which was similar to the LTR34 Kd2 value.
Comparison of these values with our previous Kd values
obtained in the absence of Mg
2+ (i.e. Kd1  2.1nM and
Kd2  55mM for LTR34 and Kd  65mM for LTR32) (28)
reveals that Mg
2+ strengthens the high aﬃnity binding
between K156 and LTR34; however, it impairs low
aﬃnity binding in both LTR34 and LTR32.
Thus, high aﬃnity binding may be dependent on
directional hydrogen bonds, which are known for their
resistance to changes in salt concentration, and possible
Nucleic Acids Research, 2009,Vol.37, No. 22 7695non-polar forces that are generally strengthened by salt
addition (58). In contrast, low aﬃnity binding that is
impaired by salt addition is mediated by ionic interactions
between negatively charged phosphate groups of the DNA
backbone and positively charged side chain groups of the
peptide.
Stabilization of high aﬃnity binding in unprocessed
LTR (LTR34) by Mg
2+ suggests the binding of a
divalent cation to the processing site CA#GT30.M g
2+ is
known for its strong preference for the guanine base,
although the adjacent base pair in the sequence usually
cooperates in this interaction (38). Note that, in the
crystal structure of the [d(CCAGTACTGG)]2 duplex,
the divalent ion binds the 50CAGT30 sequence in the
major groove, at either the ApG or GpT step (41,59).
The solvated Mg
2+ formed hydrogen bonds with
guanine and adenine bases through its water molecules;
the major groove was compressed at the ion binding
site. This resulted in an opening of the minor groove,
exactly where IN is supposed to perform its nucleophilic
attack at LTR ends. Clearly, in a mechanism of two-ion
catalysis, as the one generally assumed for IN, an Mg
2+
ion positioned in the major groove may play the role of
the second ion. Once detected and liganded by the
carboxylate groups of catalytic residues this Mg
2+ may
assist the enzyme to cleave the appropriate phosphodiester
bond. Note that in crystallographic studies the less
compact Ca
2+ also binds with high eﬃciency to the
ApG and GpT steps, but its binding mode diﬀers from
that of Mg
2+ (41). The same diﬀerence in binding may
exist between Mg
2+ and Mn
2+, explaining the biological
diﬀerences observed between these two ions in in vitro
experiments.
Analysis of peptide binding to DNA by
1H NMR
Proton chemical shift deviations (CSDs) may aid the iden-
tiﬁcation of interacting regions in structures of complexed
proteins and nucleic acids (60). In general, the CSDs of
only one partner are used to certify the interaction (61).
Here we investigated CSDs of both K156 and LTR34 to
map the interface of the peptide–DNA complex in the
presence of Mg
2+. Fluorescence experiments indicated a
signiﬁcant diﬀerence between the high aﬃnity binding Kd
( 1nM) and the low aﬃnity binding Kd ( 100mM); these
Figure 3. Fluorescence anisotropy titration of (A) LTR34 by peptide
K156 in presence (Red line) and absence (Black line) of Mg
2+;
(B) LTR32 by peptide K156 in presence (Red line) and absence
(Black line) of Mg
2+. Phosphate buﬀer pH 6, I=0.1, at 5 C, MgCl2
5mM ﬁnal concentration.
Figure 2. CD of unbound and bound K156 in the presence of Mg
2+.
(A) Spectrum of K156 at 12mM (Black line); diﬀerence spectrum
[K156+LTR34]—LTR34 at 12mM each (Red line). (B) Spectrum of
K156 at 12mM (Black line); diﬀerence spectrum [K156+LTR32]—
LTR32 at 12mM each (Red line). Phosphate buﬀer pH 6, I=0.1, at
5 C, MgCl2 5mM ﬁnal concentration.
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the speciﬁc complex occurs more frequently than the non-
speciﬁc complex. Yet, at the millimolar concentrations
required by NMR, an equimolecular 1:1 complex was
not attainable without material aggregation. To avoid a
too much signal broadening and achieve a convenient
mapping of the K156 and LTR interface, spectra were
recorded at DNA–peptide ratios of 1:5 and 1:2.
aH-NH regions of the TOCSY spectra of K156 alone
and K156 with DNA (DNA:peptide ratio of 1:5) are given
in the Supplementary Figure S2. The speciﬁc K156
binding site on LTR34 was fully saturated at this ratio,
although some non-speciﬁc binding was likely to occur.
The CSDs for the base and ribose protons of LTR34
bound to K156 at a DNA: peptide ratio of 1:5, relative
to unbound DNA (in the presence of Mg
2+), are given in
Supplementary Table S3. Assuming that only CSDs values
 0.05p.p.m. indicate interaction we can infer that eleven
nucleotide bases interact with the K156 amino acid
residues (Figure 4). These are asymmetrically distributed
between the two strands, with eight of them on the upper
strand (the one that undergoes processing) and only three
on the lower strand. Four of the aﬀected bases belong to
the same base pairs, A35.T3 and A25.T13, whereas two
other bases, C28 and A9, are in close spatial proximity in
the double helix. The A35 nucleotide, constitutive of the
highly conserved CpA step, essential to the viral DNA
integration, is among these nucleotides. Once again, the
role of GT30 next to the conserved CpA step was high-
lighted: both the guanine and thymine base protons
displayed signiﬁcant CSDs. The large CSD of the
guanine imino proton (0.23p.p.m.) suggested a signiﬁcant
change in base arrangement; however, the corresponding
signal in the NOESY spectrum showed no change, sug-
gesting that stability of the G36.C2 base pair was not
impaired by the interaction of LTR34 with K156.
The high number of desoxyribose sugars aﬀected by the
binding of K156 was also remarkable (Supplementary
Table S3). Binding contacts extend inward, about 15 or
16 base pairs from the right end of the LTR (Figure 4).
Remarkably, the binding pattern was similar to the
30-processing pattern observed by Esposito and Craigie
with 21 base pair LTR DNAs and the whole enzyme
(23). There authors found that in addition to the
six commonly outermost nucleotides AGCACT30, the
adenine (AAAA) tract in the distal LTR was also
involved in viral DNA recognition by IN; our previous
work (28) also suggested the implication of the adenine
tract in binding between K156 and LTR. Furthermore,
present ﬁndings resemble those on the stepwise increase
in LTR length versus IN binding, mutational analysis,
chemical modiﬁcations and photo cross-linking experi-
ments, as well as those of DNA protection against
DNase in the IN–viral LTR DNA complex (23,47,62–
64). That the full enzyme recognizes the whole oligo-
nucleotide (23) is conceivable, but how the relatively
small a4 peptide recognizes both the terminal ACGT30
and the internal A-tract remains unclear.
NMR data describing the binding of K156 were
obtained at a DNA:peptide ratio of 1:2 (at 700MHz).
Under these conditions,  50% of K156 was bound to
LTR34. Thus, the so measured CSDs should be weaker
than CSDs obtained for an equimolecular complex. Both
the side chain and backbone protons of several K156
residues underwent shifts in the complex. The backbone
NH and aH protons may be inﬂuenced by local functional
group contacts, and reﬂect to a good degree the changes
to residues nearest the binding site (61,65). The chemical
shifts for bound and unbound K156 are given in
Supplementary Table S4. Overall, aH CSDs were larger
than NH CSDs (an average of 0.09ppm versus an average
of 0.03p.p.m.). The aHs and NHs of residues Asn155,
Lys156, Lys159, Glu(Ser)153, Glu152, Leu(Ile)161 and
Leu(Ile)162 were most aﬀected during binding (Figure
5). Unfortunately, Gln148 could not be identiﬁed in our
spectra. All of these residues, except Leu161(Ile) and
Leu162(Ile), formed the polar/charged face of the a4
helix (Figure 6). The binding of residues Lys156, Lys159
and Gln148 to viral LTR ends has already been shown
through cross-linking experiments (23,44–46,48,49,51),
whereas the binding of the Asn155 residue has been pre-
dicted by molecular modeling (57). Among these, the two
positively charged residues Lys156 and Lys159 are
required for high aﬃnity binding between K156 and the
U5 LTR (28). Lys156, Lys159 and Asn155 have been
further shown to interact with the L731–988 derivative
(66) and 5CITEP (67), two IN inhibitors supposed to
interact at the DNA–protein interface. On another hand
the CSD exhibited by Leu161 could be attributed to
changes caused by interactions occurring with residues
in close proximity or by the dissociation of K156
multimers stabilized by hydrophobic residues (68).
Possible DNA–peptide contacts
The LTR34 oligonucleotide is composed of 34
nucleotides, and 11 of the ﬁrst 15 nucleotides interact
with K156 via their bases (Figure 4). Most of these are
important for 30-processing (23). There is a good statistical
correlation between the frequency of nucleobase conser-
vation in DNAs and the interaction of these bases with
protein amino acid side chains (69). At the same time,
most of the a4 helix amino acids interacting with LTR
DNA are themselves conserved residues, recognized for
Figure 4. The LTR34 double helix aﬀected by K156 interactions. The
LTR structures presented are taken from Renisio et al, 2005. Purple
and cyan circles indicate the bases whose chemical shifts are most
aﬀected (CSDs: purple 0.1ppm; 0.05ppm cyan<0.1ppm) by K156
(DNA:peptide ratio of 1:5).
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infectivity (33,45). This suggests that DNA–protein recog-
nition proceeds through the interaction of conserved com-
plementary domains. Tight binding requires an optimal
number of contacts between the amino acid chains and
the bases, and also the backbone phosphates and sugars.
These contacts include ionic interactions, van der Waals
forces, and hydrogen bonds. Lys and Gln belong to a
category of residues having side chains forming bidentate
interactions with DNA bases, which in general provide
higher speciﬁcity than those using single hydrogen bonds
(70). The positively charged side chain of Lys is also
frequently found in ionic interactions with DNA phos-
phate groups. For instance, the conserved Lys159
has been shown to interact with the adenine base and
phosphate group of invariant CpA (47,48). Moreover,
Lys159, together with Lys156, belongs to the Lys-rich
sequence 156 Lys Glu Leu Lys Lys160, which has been
implicated in the speciﬁc binding of IN to DNA (33). The
base of adenine in CpA (and that of its complementary
thymine) is also in contact with the catalytic Glu152
residue of the a4 helix (54). The Gln148 residue (not
identiﬁed in our spectra) has been shown to interact
with the adenine (23) and the cytosine (46) of the 50AC
overhang in processed LTR.
However, most importantly, Mg
2+ is implicated in
the speciﬁc recognition of U5 LTR by the a4 helix of
IN. How Mg
2+ impacts the recognition? Mg
2+ displays
a high preference for guanine in crystal structures of DNA
duplexes that are in either the A or B form (41,71).
In several oligonucleotide crystals, Mg
2+ has been
identiﬁed within the major and the minor groove of
ApG and GpT steps (41), which in LTRs are constitutive
to the 30-processing site. The base binding of Mg
2+ in the
major groove may cause helix bending by base-roll com-
pression toward the major groove (41), which may then
favor DNA cleavage from the minor groove. In fact,
the CSDs for both aromatic and sugar protons strongly
suggest that both the base and the scissile phosphodiester
group of adenine are involved in interactions.
Thus, binding of the Glu 152 carboxylic group may be
mediated by the preferential binding of Mg
2+ to this
group.
CONCLUSION
Our data support the idea of a tight complex between viral
DNA and IN formed through both speciﬁc interactions,
involving amino acid side chains with DNA bases, and
non-speciﬁc interactions involving amino acid side
chains and DNA backbone groups. This suggests a recog-
nition of viral DNA at the U5 LTR end that combines a
direct and an indirect readout mechanism. In the indirect
readout mechanism, the DNA sequence governs the
geometry of the binding site, and thus the quality of inter-
action among amino acid side chains and backbone sugar
and phosphate groups is strongly related to the sequence
of the DNA. The direct readout mechanism involves
direct contacts between protein functional groups and
the DNA bases in appropriate geometry. Overall, the
precise recognition of LTRs by IN is the result of the
formation of a large network of interactions between
the two partners. In this respect, the mechanism presented
here resorts to many of the same basic features commonly
found in the formation of speciﬁc DNA–protein
complexes. Yet, it signiﬁcantly diﬀers from the
Figure 5. CSDs for the aHs (A) and NHs (B) of K156 bound to
LTR34 at a DNA:peptide ratio of 1:2. Non-assigned residues are
indicated by a dot.
Figure 6. Backbone of the amphipathic K156 helix with residues of its
polar/charged face (pink) that are most aﬀected by LTR34, at a DNA:
peptide ratio of 1:2. Yellow residues (Glu156, Leu161 and Leu162) are
substituted residues showing CSD variations upon complex formation.
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on the bases of chemical modiﬁcations and nucleotide
substitutions, as well as of a stepwise increase in DNA–
ligand complexity (47,64,72). Such modiﬁcations in DNA
may have eﬀects on structural and energetic properties of
local but also distant interactions, preventing a straight-
forward analysis of the binding.
Obviously, the mechanism through which IN recognizes
the LTR ends requires further understanding, and the
analysis must be extended to other regions of the
protein. Yet, our results already shed light on the impli-
cation of the a4 helix and the divalent Mg
2+ ion in the
speciﬁc binding between IN and viral LTR DNA. The
speciﬁc binding involves complementary conserved
amino acid residues and nucleotides, suggesting that the
IN a4 helix contains most of the speciﬁcity features that
are required for a precise recognition of viral DNA, espe-
cially at the 30-processing site. Clearly, a model that would
reproduce the relevant binding properties of the enzyme
could improve our understanding of the mechanisms
underlying complex formation and might also facilitate
the design of drugs blocking viral integration.
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